Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Titel:
Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities
Kurztitel:
EMA/CHMP/ CVMP/ SWP/169430/2012
Herkunft/Verlag:

European Commission, Enterprise and Industry; http://ec.europa.eu/enterprise/

Dokumentenart:
Guideline
Inhalt:
Die Guideline beschreibt, wie die maximal erlaubte Menge eines Vorprodukts in einem Produkt ermittelt wird.

Zurück

GMP Seminare nach Thema